UniProt ID | PAXI_HUMAN | |
---|---|---|
UniProt AC | P49023 | |
Protein Name | Paxillin | |
Gene Name | PXN | |
Organism | Homo sapiens (Human). | |
Sequence Length | 591 | |
Subcellular Localization | Cytoplasm, cytoskeleton . Cell junction, focal adhesion . Cytoplasm, cell cortex . Colocalizes with integrins at the cell periphery. Colocalize with PXN to membrane ruffles and the leading edge of migrating cells (PubMed:23128389). | |
Protein Description | Cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion).. | |
Protein Sequence | MDDLDALLADLESTTSHISKRPVFLSEETPYSYPTGNHTYQEIAVPPPVPPPPSSEALNGTILDPLDQWQPSSSRFIHQQPQSSSPVYGSSAKTSSVSNPQDSVGSPCSRVGEEEHVYSFPNKQKSAEPSPTVMSTSLGSNLSELDRLLLELNAVQHNPPGFPADEANSSPPLPGALSPLYGVPETNSPLGGKAGPLTKEKPKRNGGRGLEDVRPSVESLLDELESSVPSPVPAITVNQGEMSSPQRVTSTQQQTRISASSATRELDELMASLSDFKIQGLEQRADGERCWAAGWPRDGGRSSPGGQDEGGFMAQGKTGSSSPPGGPPKPGSQLDSMLGSLQSDLNKLGVATVAKGVCGACKKPIAGQVVTAMGKTWHPEHFVCTHCQEEIGSRNFFERDGQPYCEKDYHNLFSPRCYYCNGPILDKVVTALDRTWHPEHFFCAQCGAFFGPEGFHEKDGKAYCRKDYFDMFAPKCGGCARAILENYISALNTLWHPECFVCRECFTPFVNGSFFEHDGQPYCEVHYHERRGSLCSGCQKPITGRCITAMAKKFHPEHFVCAFCLKQLNKGTFKEQNDKPYCQNCFLKLFC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDDLDALL -------CCHHHHHH | 9.03 | 19413330 | |
2 (in isoform 4) | Acetylation | - | 66.24 | 22814378 | |
2 (in isoform 4) | Phosphorylation | - | 66.24 | 25159151 | |
3 (in isoform 4) | Phosphorylation | - | 45.19 | 25159151 | |
4 (in isoform 4) | Phosphorylation | - | 3.46 | 29507054 | |
19 | Phosphorylation | ESTTSHISKRPVFLS HHHCCCHHCCCEECC | 19.72 | - | |
26 | Phosphorylation | SKRPVFLSEETPYSY HCCCEECCCCCCCCC | 23.17 | 26356563 | |
29 | Phosphorylation | PVFLSEETPYSYPTG CEECCCCCCCCCCCC | 24.39 | 26356563 | |
31 | Phosphorylation | FLSEETPYSYPTGNH ECCCCCCCCCCCCCC | 28.40 | 15572663 | |
32 | Phosphorylation | LSEETPYSYPTGNHT CCCCCCCCCCCCCCE | 26.32 | 26356563 | |
33 | Phosphorylation | SEETPYSYPTGNHTY CCCCCCCCCCCCCEE | 10.04 | 26356563 | |
35 | Phosphorylation | ETPYSYPTGNHTYQE CCCCCCCCCCCEEEE | 42.24 | 26356563 | |
39 | Phosphorylation | SYPTGNHTYQEIAVP CCCCCCCEEEEEECC | 30.79 | 26356563 | |
40 | Phosphorylation | YPTGNHTYQEIAVPP CCCCCCEEEEEECCC | 9.15 | 26356563 | |
74 | O-linked_Glycosylation | DQWQPSSSRFIHQQP HHCCCCCCCCCCCCC | 35.23 | 30059200 | |
83 | O-linked_Glycosylation | FIHQQPQSSSPVYGS CCCCCCCCCCCCCCC | 39.19 | 30059200 | |
83 | Phosphorylation | FIHQQPQSSSPVYGS CCCCCCCCCCCCCCC | 39.19 | 22167270 | |
84 | Phosphorylation | IHQQPQSSSPVYGSS CCCCCCCCCCCCCCC | 33.15 | 22167270 | |
85 | O-linked_Glycosylation | HQQPQSSSPVYGSSA CCCCCCCCCCCCCCC | 24.51 | 30059200 | |
85 | Phosphorylation | HQQPQSSSPVYGSSA CCCCCCCCCCCCCCC | 24.51 | 22167270 | |
87 | Phosphorylation | QPQSSSPVYGSSAKT CCCCCCCCCCCCCCC | 10.25 | 17016520 | |
88 | Phosphorylation | PQSSSPVYGSSAKTS CCCCCCCCCCCCCCC | 18.06 | 25159151 | |
90 | O-linked_Glycosylation | SSSPVYGSSAKTSSV CCCCCCCCCCCCCCC | 14.94 | 30059200 | |
90 | Phosphorylation | SSSPVYGSSAKTSSV CCCCCCCCCCCCCCC | 14.94 | 21945579 | |
91 | Phosphorylation | SSPVYGSSAKTSSVS CCCCCCCCCCCCCCC | 29.44 | 21945579 | |
94 | Phosphorylation | VYGSSAKTSSVSNPQ CCCCCCCCCCCCCCC | 26.42 | 23927012 | |
95 | Phosphorylation | YGSSAKTSSVSNPQD CCCCCCCCCCCCCCC | 28.21 | 23927012 | |
96 | Phosphorylation | GSSAKTSSVSNPQDS CCCCCCCCCCCCCCC | 34.49 | 23927012 | |
98 | Phosphorylation | SAKTSSVSNPQDSVG CCCCCCCCCCCCCCC | 44.75 | 30266825 | |
103 | Phosphorylation | SVSNPQDSVGSPCSR CCCCCCCCCCCCCCC | 24.11 | 30266825 | |
106 | Phosphorylation | NPQDSVGSPCSRVGE CCCCCCCCCCCCCCC | 22.15 | 19664994 | |
108 | S-nitrosylation | QDSVGSPCSRVGEEE CCCCCCCCCCCCCCC | 4.31 | 22126794 | |
109 | Phosphorylation | DSVGSPCSRVGEEEH CCCCCCCCCCCCCCC | 33.13 | 30266825 | |
117 | Phosphorylation | RVGEEEHVYSFPNKQ CCCCCCCEEECCCCC | 4.91 | 17016520 | |
118 | Phosphorylation | VGEEEHVYSFPNKQK CCCCCCEEECCCCCC | 13.40 | 29255136 | |
119 | Phosphorylation | GEEEHVYSFPNKQKS CCCCCEEECCCCCCC | 32.89 | 29255136 | |
123 | Ubiquitination | HVYSFPNKQKSAEPS CEEECCCCCCCCCCC | 60.38 | - | |
125 | Ubiquitination | YSFPNKQKSAEPSPT EECCCCCCCCCCCCC | 53.92 | - | |
125 (in isoform 4) | Phosphorylation | - | 53.92 | 25311616 | |
126 | Phosphorylation | SFPNKQKSAEPSPTV ECCCCCCCCCCCCCE | 35.06 | 29255136 | |
128 (in isoform 4) | Phosphorylation | - | 54.09 | 24719451 | |
130 | Phosphorylation | KQKSAEPSPTVMSTS CCCCCCCCCCEEECC | 25.38 | 29255136 | |
132 | Phosphorylation | KSAEPSPTVMSTSLG CCCCCCCCEEECCCC | 32.93 | 30266825 | |
134 | Sulfoxidation | AEPSPTVMSTSLGSN CCCCCCEEECCCCCC | 3.88 | 30846556 | |
135 | Phosphorylation | EPSPTVMSTSLGSNL CCCCCEEECCCCCCH | 15.54 | 30266825 | |
136 | Phosphorylation | PSPTVMSTSLGSNLS CCCCEEECCCCCCHH | 15.18 | 29255136 | |
137 | Phosphorylation | SPTVMSTSLGSNLSE CCCEEECCCCCCHHH | 24.35 | 19664994 | |
139 (in isoform 4) | Phosphorylation | - | 17.79 | 29507054 | |
140 | Phosphorylation | VMSTSLGSNLSELDR EEECCCCCCHHHHHH | 39.63 | 30278072 | |
141 (in isoform 4) | Phosphorylation | - | 45.87 | 24275569 | |
143 | Phosphorylation | TSLGSNLSELDRLLL CCCCCCHHHHHHHHH | 40.12 | 23927012 | |
151 (in isoform 4) | Phosphorylation | - | 39.69 | 18691976 | |
154 (in isoform 4) | Phosphorylation | - | 18.25 | 25159151 | |
155 (in isoform 4) | Phosphorylation | - | 6.06 | 29743597 | |
169 | Phosphorylation | FPADEANSSPPLPGA CCCCCCCCCCCCCCC | 51.80 | 26356563 | |
170 | Phosphorylation | PADEANSSPPLPGAL CCCCCCCCCCCCCCC | 30.28 | 30278072 | |
178 | Phosphorylation | PPLPGALSPLYGVPE CCCCCCCCCCCCCCC | 16.60 | 30278072 | |
181 | Phosphorylation | PGALSPLYGVPETNS CCCCCCCCCCCCCCC | 21.33 | 27259358 | |
186 | Phosphorylation | PLYGVPETNSPLGGK CCCCCCCCCCCCCCC | 34.62 | 26356563 | |
188 | Phosphorylation | YGVPETNSPLGGKAG CCCCCCCCCCCCCCC | 28.99 | 26356563 | |
216 | Phosphorylation | GLEDVRPSVESLLDE CHHHHCHHHHHHHHH | 28.14 | 29496963 | |
219 | Phosphorylation | DVRPSVESLLDELES HHCHHHHHHHHHHHH | 31.88 | 22199227 | |
226 | Phosphorylation | SLLDELESSVPSPVP HHHHHHHHCCCCCCC | 49.62 | 29523821 | |
227 | Phosphorylation | LLDELESSVPSPVPA HHHHHHHCCCCCCCE | 28.77 | 29523821 | |
230 | Phosphorylation | ELESSVPSPVPAITV HHHHCCCCCCCEEEE | 36.05 | 28192239 | |
236 | Phosphorylation | PSPVPAITVNQGEMS CCCCCEEEECCCCCC | 18.60 | 23663014 | |
243 | Phosphorylation | TVNQGEMSSPQRVTS EECCCCCCCCCCCCC | 34.27 | 25159151 | |
244 | Phosphorylation | VNQGEMSSPQRVTST ECCCCCCCCCCCCCH | 24.60 | 25159151 | |
249 | Phosphorylation | MSSPQRVTSTQQQTR CCCCCCCCCHHHHHH | 28.39 | 23403867 | |
250 | Phosphorylation | SSPQRVTSTQQQTRI CCCCCCCCHHHHHHH | 22.74 | 27273156 | |
251 | Phosphorylation | SPQRVTSTQQQTRIS CCCCCCCHHHHHHHC | 22.49 | 23403867 | |
255 | Phosphorylation | VTSTQQQTRISASSA CCCHHHHHHHCCHHH | 26.15 | 23403867 | |
258 | Phosphorylation | TQQQTRISASSATRE HHHHHHHCCHHHHHH | 20.86 | 30266825 | |
258 (in isoform 2) | Phosphorylation | - | 20.86 | 25311616 | |
260 | Phosphorylation | QQTRISASSATRELD HHHHHCCHHHHHHHH | 17.45 | 30266825 | |
261 | Phosphorylation | QTRISASSATRELDE HHHHCCHHHHHHHHH | 33.12 | 27273156 | |
261 (in isoform 2) | Phosphorylation | - | 33.12 | 24719451 | |
263 | Phosphorylation | RISASSATRELDELM HHCCHHHHHHHHHHH | 26.99 | 22167270 | |
270 | Sulfoxidation | TRELDELMASLSDFK HHHHHHHHHHHCCCE | 1.93 | 30846556 | |
272 | Phosphorylation | ELDELMASLSDFKIQ HHHHHHHHHCCCEEC | 17.91 | 23911959 | |
272 (in isoform 2) | Phosphorylation | - | 17.91 | 29507054 | |
274 | Phosphorylation | DELMASLSDFKIQGL HHHHHHHCCCEECCC | 38.21 | 23403867 | |
274 (in isoform 2) | Phosphorylation | - | 38.21 | 24275569 | |
277 | Ubiquitination | MASLSDFKIQGLEQR HHHHCCCEECCCHHH | 38.83 | 21906983 | |
284 (in isoform 2) | Phosphorylation | - | 25.85 | 18691976 | |
287 (in isoform 2) | Phosphorylation | - | 24.22 | 25159151 | |
288 (in isoform 2) | Phosphorylation | - | 45.25 | 29743597 | |
302 | Phosphorylation | WPRDGGRSSPGGQDE CCCCCCCCCCCCCCC | 44.13 | 22167270 | |
303 | Phosphorylation | PRDGGRSSPGGQDEG CCCCCCCCCCCCCCC | 26.63 | 22167270 | |
311 (in isoform 3) | Phosphorylation | - | 13.70 | 24114839 | |
313 (in isoform 3) | Phosphorylation | - | 2.85 | 24114839 | |
316 (in isoform 3) | Phosphorylation | - | 21.69 | 21815630 | |
318 | Phosphorylation | GFMAQGKTGSSSPPG CCCCCCCCCCCCCCC | 49.47 | 22167270 | |
320 | Phosphorylation | MAQGKTGSSSPPGGP CCCCCCCCCCCCCCC | 32.64 | 22167270 | |
321 | Phosphorylation | AQGKTGSSSPPGGPP CCCCCCCCCCCCCCC | 48.48 | 22167270 | |
322 | Phosphorylation | QGKTGSSSPPGGPPK CCCCCCCCCCCCCCC | 36.49 | 22167270 | |
332 | Phosphorylation | GGPPKPGSQLDSMLG CCCCCCCHHHHHHHH | 35.78 | 23927012 | |
332 (in isoform 3) | Phosphorylation | - | 35.78 | 25849741 | |
334 (in isoform 3) | Phosphorylation | - | 5.88 | 27762562 | |
335 (in isoform 3) | Phosphorylation | - | 25.10 | 25849741 | |
336 | Phosphorylation | KPGSQLDSMLGSLQS CCCHHHHHHHHHHHH | 25.21 | 30266825 | |
336 (in isoform 3) | Phosphorylation | - | 25.21 | 25849741 | |
340 | Phosphorylation | QLDSMLGSLQSDLNK HHHHHHHHHHHHHHH | 21.19 | 30266825 | |
343 | Phosphorylation | SMLGSLQSDLNKLGV HHHHHHHHHHHHHCH | 49.73 | 23927012 | |
352 | Phosphorylation | LNKLGVATVAKGVCG HHHHCHHHHHCCCCC | 20.70 | 28857561 | |
355 | Acetylation | LGVATVAKGVCGACK HCHHHHHCCCCCCCC | 47.76 | 25953088 | |
355 | Ubiquitination | LGVATVAKGVCGACK HCHHHHHCCCCCCCC | 47.76 | - | |
371 | Phosphorylation | PIAGQVVTAMGKTWH CCCCCEEECCCCCCC | 16.45 | 21406692 | |
404 | Phosphorylation | FERDGQPYCEKDYHN CCCCCCCCCCCCCHH | 12.83 | 28152594 | |
409 | Phosphorylation | QPYCEKDYHNLFSPR CCCCCCCCHHCCCCC | 12.04 | 28152594 | |
414 | Phosphorylation | KDYHNLFSPRCYYCN CCCHHCCCCCEEEEC | 18.01 | 25159151 | |
468 | Phosphorylation | KAYCRKDYFDMFAPK CEEECHHHHHHCCCC | 12.43 | 20562096 | |
471 | Sulfoxidation | CRKDYFDMFAPKCGG ECHHHHHHCCCCCCH | 1.90 | 30846556 | |
533 | Phosphorylation | HYHERRGSLCSGCQK EEECCCCCCCCCCCC | 25.13 | 23927012 | |
536 | Phosphorylation | ERRGSLCSGCQKPIT CCCCCCCCCCCCCCC | 48.15 | 23927012 | |
540 | Acetylation | SLCSGCQKPITGRCI CCCCCCCCCCCHHHH | 42.33 | 26210075 | |
540 | Ubiquitination | SLCSGCQKPITGRCI CCCCCCCCCCCHHHH | 42.33 | - | |
543 | Phosphorylation | SGCQKPITGRCITAM CCCCCCCCHHHHHHH | 27.40 | - | |
553 | Acetylation | CITAMAKKFHPEHFV HHHHHHHHHCHHHHH | 39.09 | 26051181 | |
554 (in isoform 3) | Ubiquitination | - | 13.16 | - | |
570 | Malonylation | FCLKQLNKGTFKEQN HHHHHHCCCCCCCCC | 68.84 | 26320211 | |
574 | Acetylation | QLNKGTFKEQNDKPY HHCCCCCCCCCCCCC | 59.22 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
31 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
31 | Y | Phosphorylation | Kinase | EPHB1 | P54762 | GPS |
31 | Y | Phosphorylation | Kinase | PTK2 | Q05397 | GPS |
31 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | GPS |
31 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | Uniprot |
40 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
40 | Y | Phosphorylation | Kinase | SRC | P12931 | GPS |
83 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
83 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
85 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
85 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
88 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
88 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
118 | Y | Phosphorylation | Kinase | FYN | P06241 | PSP |
118 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
118 | Y | Phosphorylation | Kinase | EPHB1 | P54762 | GPS |
118 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | GPS |
118 | Y | Phosphorylation | Kinase | PTK2 | Q05397 | GPS |
118 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | Uniprot |
126 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
126 | S | Phosphorylation | Kinase | GSK-FAMILY | - | GPS |
126 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
130 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
130 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
178 | S | Phosphorylation | Kinase | MAPK8 | P45983 | GPS |
244 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
244 | S | Phosphorylation | Kinase | CDK5 | Q00535 | Uniprot |
250 | S | Phosphorylation | Kinase | SLK | Q9H2G2 | Uniprot |
258 | S | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
272 | S | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
272 | S | Phosphorylation | Kinase | PAK2 | Q13177 | PSP |
272 | S | Phosphorylation | Kinase | PAK4 | O96013 | PSP |
274 | S | Phosphorylation | Kinase | PAK2 | Q13177 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF5 | Q99942 | PMID:12861019 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PAXI_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-106, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85 AND SER-126, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-85 AND THR-318,AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-106, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-106; SER-126;SER-130 AND SER-137, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-84; TYR-88 AND TYR-118,AND MASS SPECTROMETRY. | |
"Cdk5 regulates differentiation of oligodendrocyte precursor cellsthrough the direct phosphorylation of paxillin."; Miyamoto Y., Yamauchi J., Chan J.R., Okada A., Tomooka Y.,Hisanaga S., Tanoue A.; J. Cell Sci. 120:4355-4366(2007). Cited for: PHOSPHORYLATION AT SER-244. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-118 AND SER-303, ANDMASS SPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-31; TYR-88 AND TYR-118,AND MASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-88 AND TYR-118, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-118, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-118, AND MASSSPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-118, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of HeLa cells using stable isotope labelingwith amino acids in cell culture (SILAC)."; Amanchy R., Kalume D.E., Iwahori A., Zhong J., Pandey A.; J. Proteome Res. 4:1661-1671(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-88 AND TYR-118, AND MASSSPECTROMETRY. | |
"Brk activates rac1 and promotes cell migration and invasion byphosphorylating paxillin."; Chen H.Y., Shen C.H., Tsai Y.T., Lin F.C., Huang Y.P., Chen R.H.; Mol. Cell. Biol. 24:10558-10572(2004). Cited for: PHOSPHORYLATION AT TYR-31 AND TYR-118, AND INTERACTION WITH PTK6. | |
"Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin inMM1 cancer cell migration."; Iwasaki T., Nakata A., Mukai M., Shinkai K., Yano H., Sabe H.,Schaefer E., Tatsuta M., Tsujimura T., Terada N., Kakishita E.,Akedo H.; Int. J. Cancer 97:330-335(2002). Cited for: PHOSPHORYLATION AT TYR-31; TYR-118 AND TYR-181. |